GOT1 is overexpressed in many CRC cell lines, and its inhibition sensitizes CRC cells to 5-fluorouracil (5-FU) by compromising their defenses against 5-FU-induced reactive oxygen species (ROS) [48]. This evidence concerns the gene GOT1 and colorectal carcinoma.